| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | CN1812983A Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 08/02/2006 | CN1812982A Benzodiazepine cgrp receptor antagonists |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812787A 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 08/02/2006 | CN1812782A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 08/02/2006 | CN1810807A Substituted guanidine derivatives |
| 08/02/2006 | CN1810805A Synthesis of domperidone maleate |
| 08/02/2006 | CN1810804A Prepn process of [(substituted pyridyl) methyl] sulfenyl-1H-benzimidazole compound and its antimer zinc salt |
| 08/02/2006 | CN1810803A Selective prepn process of (S)-Omeprazole with high antimer |
| 08/02/2006 | CN1810802A 3-substituted-4-pyrimidone derivatives |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/01/2006 | US7084276 Phenyl quinolines and their use as estrogenic agents |
| 08/01/2006 | US7084169 Aminoalkoxyindoles and methods of use |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084163 Applying to plants |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7084145 Triazole compounds useful in therapy |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084124 Antidiabetic agents; insulin resistance |
| 08/01/2006 | US7083986 Acridinium compound for use in the concurrent detection of target analytes in immunoassays or nucleic acid assays |
| 08/01/2006 | US7083982 Fluorescence staining of reticulocytes |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 08/01/2006 | CA2236851C Substituted vinylpyridine derivatives and drugs containing the same |
| 07/27/2006 | WO2006078907A1 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments |
| 07/27/2006 | WO2006078775A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | WO2006078697A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/27/2006 | WO2006078621A2 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006078006A1 Indole compound and pharmaceutical composition containing the same |
| 07/27/2006 | WO2006077984A1 Fluoroalkylpyrrolidine derivative |
| 07/27/2006 | WO2006077861A1 Polyamine derivative and polyol derivative |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077499A1 Chemical compounds |
| 07/27/2006 | WO2006077496A1 Substituted triazole derivatives as oxytocin antagonists |
| 07/27/2006 | WO2006077426A2 4- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS |
| 07/27/2006 | WO2006077419A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | WO2006077416A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | WO2006077414A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | WO2006077387A2 Novel benzamide derivatives |
| 07/27/2006 | WO2006077367A1 Indoles useful in the treatment of inflamation |
| 07/27/2006 | WO2006077366A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006077365A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006077364A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006077070A1 Chemical compounds, process for their preparation and use thereof |
| 07/27/2006 | WO2006077026A1 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-i) inhibitors for the treatment of neurological and neuropsychiatry disorders |
| 07/27/2006 | WO2006054143A8 Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine |
| 07/27/2006 | WO2006050480A3 Substituted pyridines with activity on syk kinase |
| 07/27/2006 | WO2006036981A3 Small molecule modulators of cytokine activity |
| 07/27/2006 | WO2006026204A3 Novel gamma-lactams as beta-secretase inhibitors |
| 07/27/2006 | WO2006012226A3 N-substituted piperidines and their use as pharmaceuticals |
| 07/27/2006 | WO2006007501A3 Mitotic kinesin inhibitors |
| 07/27/2006 | WO2005075454A3 SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE |
| 07/27/2006 | WO2005061466A9 Novel phenylalanine derivative |
| 07/27/2006 | WO2005051304A3 Akt protein kinase inhibitors |
| 07/27/2006 | WO2005048954A3 Continuous process for producing hydroxyazapirones by oxidation |
| 07/27/2006 | US20060167265 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/27/2006 | US20060167262 Enantioselective sulphoxidation of 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methylthio]-1H-benzimidazole using cumene hydroperoxide in the presence of a chiral hafnium or zirconium complex; industrial scale |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167060 pyrazolecarboxanilide derivatives such as N-(2-chloro-6-methylphenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used for controlling pests; effective, less costly, less toxic and environmentally friendly pesticides |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167047 Tetrahydorquinoline derivatives and their use as fsh receptor modulators |
| 07/27/2006 | US20060167046 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 07/27/2006 | US20060167044 Piperidine derivatives and their use as anti-inflammatory agents |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167015 Inhibitors of tyrosine kinases |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166996 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/27/2006 | US20060166995 Piperidine-n-oxide-derivatives |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166986 Novel stereoselective synthesis of benzimidazole sulfoxides |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166977 Antibacterial agents |
| 07/27/2006 | US20060166966 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |